<DOC>
	<DOC>NCT01145144</DOC>
	<brief_summary>The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.</brief_summary>
	<brief_title>Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment</brief_title>
	<detailed_description />
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>previous poor response to ovarian stimulation in IVF. patients over the age of 42 patients who received DHEA at any time.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Dehydroepiandrosterone</keyword>
	<keyword>DHEA</keyword>
	<keyword>IVF outcome</keyword>
	<keyword>long protocol IVF</keyword>
	<keyword>poor-responder</keyword>
	<keyword>recombinant LH</keyword>
	<keyword>embryo quality</keyword>
	<keyword>pregnancy rate</keyword>
	<keyword>live birth rate</keyword>
	<keyword>poor response to ovarian stimulation</keyword>
</DOC>